Completed PHASE4 INTERVENTIONAL 2-arm NCT01070225

Reversal of Acute β-Blocker Induced Bronchoconstriction

Sponsor: NHS Tayside

Conditions Asthma

Interventions Hydrocortisone/ Placebo and Propranolol

Updated 6 times since 2017 Last updated: Apr 10, 2019 Started: Mar 31, 2010 Primary completion: Aug 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01070225, this PHASE4 trial focuses on Asthma and remains completed. Sponsored by NHS Tayside, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — May 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NHS Tayside
University of Dundee

Data source: University of Dundee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dundee, United Kingdom